[61B3-61B3];[61B3-61B3];
A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
61B3;61B3
Breakpoint from FlyBase's release 5 sequence location of progenitor insertion.
This deletion removes a single ribosomal protein-coding gene (though other genes are also removed).
Df(3L)miple1-2Δ104/Df(3L)BSC125 and Df(3L)BSC125/Df(3L)BSC126 males are sterile.
Df(3L)miple1-2Δ104/Df(3L)BSC125 animals are short lived.
Inferred to overlap with: Df(3L)BSC126.
Inferred to overlap with: Df(3L)miple1-2Delta104.
Visceral mesoderm founder cell specification in early development and gut formation in later development is normal in embryos derived from crosses of Df(3L)miple1-2Δ104 to Df(3L)BSC125 (to remove both maternal and zygotic miple1 and miple2).
Inferred to overlap with: Df(3L)Exel6084.
Flies heterozygous for the deletion do not show a Minute bristle phenotype.
Presence of P+PBac{XP5.WH5}BSC125 was verified using the PCR methods and primers described in FBrf0175003.
The cytological breakpoints of Df(3L)BSC125 predicted from the progenitor PBac{WH}f04555 and P{XP}d10863 transposable element insertions sites are 61B3;61B3.